Team Finland China is inviting Finnish health technology companies to participate in the visit and showcase Finnish innovative offerings in medical devices, health technology, pharmaceutical products, healthcare and digital services. We welcome Finnish companies with business interests in China to look into these opportunities to join the visit.
Hainan Free Trade Port is a Chinese government’s key initiative to make Hainan an international travel destination and innovative platform in a number of sectors. Healthcare is one of the crucial areas. One of the key healthcare industry parks at Hainan Free Trade Port is Lecheng Medical Pilot Zone. The Pilot Zone is the only place in China that provides easy market access for suppliers of international novel medical devices, health technologies, and innovative pharmaceutical products. International healthcare providers are entitled to fast-track procedures, no NMPA (ex-CFDA) licensing, real-world clinical data sharing, and reduced time of approval from 429 working days to 58 working days.
So far, more than 100 medical devices, health technologies, and innovative drugs have been introduced to Lecheng Pilot Zone. Companies offering these products and services include AstraZeneca, Johnson & Johnson, B.Braun, Boston Scientific, Medtronic, Roche Diagnostics, Pfizer, Advanced Bionics, Allergan, Cochlear, MED-EL etc. In addition, more than 10 medical institutes are already in operation at the Pilot Zone such as Boao Super Hospital, Boao Sino-French Rehab Medical Center, Boao International Hospital, Boao Evergrande International Hospital, and Cimingboao International Hospital.
Tuesday, December 1, 2020 – Seminar, business matchmaking, dinner reception
The seminar starting at 08.00 Finnish time, 14:00 Chinese time
This is a hybrid visit where part of the participants is attending online from Finland and part of visit participants are from locations in China. Mr. Jarno Syrjälä, Ambassador of Finland to China will open the seminar.
At the seminar, Finnish companies will have the possibility to present their solutions (solutions may be selected by Chinese organisers based on solutions offered) to potential Chinese partners and investors. The seminar will be followed by a business matchmaking session where all participating Finnish companies will have the opportunities to speak to interested Chinese participants (matchmaking will be organized by Chinese organizers). Both seminar and matchmaking will have an online and an on-site participation. A dinner reception will follow afterwards but will be an on-site only.
Wednesday, December 2, 2020 – Site visit to hospitals at Lecheng Pilot Zone (full day)
The visit will be an on-site visit only.
See a more detailed program here
Updated information on the program activities will be sent to participants during the course of planning.
The languages during the visit are English and Chinese. Interpreters are available. The platform for seminar and matchmaking will be Zoom.
Who should attend?
The visit is targeted to Finnish companies, located either in Finland or in China, in the field of health technologies, novel medical devices and equipment, healthcare services, and innovative pharmaceutical products.
Also companies whose products and services are relating to the whole value chain from prevention, screening and diagnostics, treatment, to rehabilitation and care.
All disease categories are welcome as the Pilot Zone is currently expanding to multi-disciplinary practice although current focus is on ophthalmology, otology, dermatology, cardiology, oncology, orthopedics, traditional Chinese medicine, fertility, rehabilitation, medicine and plastic surgery.
Participation in the visit is free of charge, however, requires a registration by 20 November 2020. Due to current travel restriction, the visit will be in hybrid form but the dinner reception and the site visit will be on-site visits only.
Kindly note that transportation and accommodation to be covered by participates.